Purpose of the development: For personalized monitoring of the tumor process, correction of treatment regimens and improving the quality of life of cancer patients.

Recommended application field: The medicine.

Advantages over analogues: Due to their stability, selectivity and specificity for a certain type of tumors, microRNAs have a significant advantage over other biomarkers. Analysis of the level of one miRNA provides comprehensive information about the tumor (risk of recurrence, degree of malignancy, sensitivity to chemo-, radio-hormonal therapy, etc.). The use of the proposed biomarker panel is highly informative, sensitive and easy.

The development stage readiness: Tested experimental exploitation order

Description of the development:
()
The method is based on the determination of a new class of highly sensitive, tissue-specific epigenetic tumor markers - miRNA and analysis of their correlation dependences with the molecular profile of tumors.

Information about newness of the development:
there are Ukrainian patents -- 1 items

corresponds technical description
Guarantees stable results getting

Possibility of transfer abroad:
Joint production, sale, exploitation

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua